Kyowa Kirin takes tivantinib into Asian Phase III trial for lung cancer
10 August 2011
Ian Haydock
Please Login to read the full article.
10 August 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Phase II success in HCC for c-MET inhibitor as monotherapy
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- Daiichi Sankyo snaffles first ripe fruit of ArQule research collaboration
- BMS seeds the oyster as it strikes Asian oncology deal with ASLAN
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
